EUCTR2006-006323-39-DE进行中（未招募）不适用
Sunphenon (Epigallocatechin-Gallate) in relapsing-remitting multiple sclerosis - Sunphenon in RR-MS
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •age 18 to 60, male and female subjects, confirmed diagnosis of relapsing-remitting multiple sclerosis according to the criteria by McDonald et al. revised in 2005, EDSS 0 to 6,5, immunomodulatory therapy with glatiramer acetate (Copaxone) for at least 9 months before screening.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •primary or secondary chronic progressive multiple sclerosis, pregnancy, clinical or laboratory findings of impaired liver function, psychiatric disorders, concomitant medication with hepatotoxic drugs.
研究者
相似试验
进行中（未招募）
1 期
Sunphenon EGCg (Epigallocatechin-Gallat) in the early stage of Alzheimer´s Disease - SUN-AKEUCTR2009-009656-20-DECharite Universitaetsmedizin Berlin50
已完成
1 期
Sunphenon Epigallocatechin-gallate (EGCg) in Relapsing-remitting Multiple Sclerosis (SuniMS Study)Relapsing-remitting Multiple SclerosisNCT00525668Charite University, Berlin, Germany120
进行中（未招募）
1 期
SUNIMUD - Sunphenon EGCg (Epigallocatechin-Gallate) in Duchenne Muscular DystrophyDuchenne Muscular DystrophyEUCTR2009-016482-28-DECharite Universitätsmedizin Berlin40
已完成
2 期
Sunphenon in Progressive Forms of Multiple SclerosisMultiple SclerosisNCT00799890Friedemann Paul61
进行中（未招募）
1 期
SUPREMES - Sunphenon in progressive forms of multiple sclerosisprimary and secondary progressive forms of multiple sclerosisEUCTR2008-005213-22-DECharite Universitätsmedizin Berlin60